Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

NCT02308111 ·Status: TERMINATED ·Phase: PHASE4

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

NCT04956328 ·Status: UNKNOWN ·Phase: PHASE3

Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis

NCT06715319 ·Status: COMPLETED ·Phase: PHASE3

Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

NCT07104201 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

NCT02078882 ·Status: COMPLETED ·Phase: PHASE4

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

NCT04376528 ·Status: UNKNOWN ·Phase: PHASE4

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

NCT02937012 ·Status: UNKNOWN ·Phase: PHASE3

Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis

NCT03668145 ·Status: UNKNOWN ·Phase: NA

Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

NCT02955602 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

NCT06591468 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA

NCT03742973 ·Status: TERMINATED ·Phase: PHASE2

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT04650243 ·Status: RECRUITING ·Phase: PHASE4

Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis

NCT01662973 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Ursodiol-Methotrexate for Primary Biliary Cirrhosis

NCT00006168 ·Status: COMPLETED ·Phase: PHASE3

Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis

NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis

NCT05450887 ·Status: COMPLETED ·Phase: PHASE3

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

NCT06755541 ·Status: RECRUITING ·Phase: PHASE3

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

NCT00179413 ·Status: COMPLETED ·Phase: PHASE4

Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis

NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1

B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis

NCT02376335 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

NCT06699121 ·Status: RECRUITING ·Phase: PHASE2

Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis

NCT06865924 ·Status: RECRUITING ·Phase: NA